Get the Stockscreener App
0.8782
0.31%
-0.0027
After Hours:
.88
0.0018
+0.20%
Xortx Therapeutics Inc stock is traded at $0.8782, with a volume of 35,890.
It is down -0.31% in the last 24 hours and up +6.28% over the past month.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
See More
Previous Close:
$0.8809
Open:
$0.8624
24h Volume:
35,890
Relative Volume:
0.58
Market Cap:
$4.58M
Revenue:
-
Net Income/Loss:
$-736.70K
P/E Ratio:
-87.82
EPS:
-0.01
Net Cash Flow:
$-4.14M
1W Performance:
-2.96%
1M Performance:
+6.28%
6M Performance:
+3.32%
1Y Performance:
-42.60%
1-Day Range:
$0.85
$0.906
1-Week Range:
$0.8272
$0.9936
52-Week Range:
$0.6608
$2.51
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Compare XRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.8782 | 4.59M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Xortx Therapeutics Inc Stock (XRTX) Latest News
How to build a custom watchlist for XORTX Therapeutics Inc.Market Activity Report & Real-Time Stock Price Movement Reports - newser.com
Will XORTX Therapeutics Inc. stock see insider buyingRisk Management & Weekly High Return Stock Opportunities - newser.com
Tools to assess XORTX Therapeutics Inc.’s risk profile2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - newser.com
What analysts say about XORTX Therapeutics Inc stockFinancial Sector Performance & Low Risk Investment Portfolio - earlytimes.in
Why XORTX Therapeutics Inc. is moving todayTake Profit & Reliable Price Action Trade Plans - newser.com
How institutional ownership impacts XORTX Therapeutics Inc. stock2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com
Is a relief rally coming for XORTX Therapeutics Inc. holdersGold Moves & AI Driven Stock Movement Reports - newser.com
XORTX Therapeutics Inc.’s volatility index tracking explainedTrade Ideas & Daily Price Action Insights - newser.com
Will XORTX Therapeutics Inc. (ANUA) stock outperform energy sector in 2025Portfolio Risk Summary & Real-Time Volume Trigger Notifications - newser.com
Is XORTX Therapeutics Inc. a candidate for recovery play2025 Volatility Report & Weekly High Conviction Trade Ideas - newser.com
What analyst consensus implies for XORTX Therapeutics Inc. (ANUA) stockJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
XORTX Therapeutics Inc. stock trend outlook and recovery pathEarnings Performance Report & Reliable Breakout Forecasts - newser.com
Will breakout in XORTX Therapeutics Inc. lead to full recovery2025 Investor Takeaways & Safe Entry Momentum Tips - newser.com
How big funds are accumulating XORTX Therapeutics Inc. (ANUA) stockEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com
Comparing XORTX Therapeutics Inc. in custom built stock radarsJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Volatility clustering patterns for XORTX Therapeutics Inc.Bond Market & Community Shared Stock Ideas - newser.com
Is XORTX Therapeutics Inc. (ANUA) stock attractive post correctionJuly 2025 Drop Watch & Reliable Price Breakout Alerts - newser.com
What’s the recovery path for long term holders of XORTX Therapeutics Inc.Market Growth Summary & AI Driven Stock Price Forecasts - newser.com
How XORTX Therapeutics Inc. (ANUA) stock stacks up against competitors2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
What drives XORTX Therapeutics Inc ANUA stock priceEarnings Date Calendar & Big Gains Small Trading - earlytimes.in
Xortx Therapeutics Inc Stock (XRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):